STAAR Surgical (NASDAQ:STAA) Trading Down 6%
STAAR Surgical (NASDAQ:STAA) Trading Down 6%
STAAR Surgical (NASDAQ:STAA – Get Rating) dropped 6% during mid-day trading on Monday . The company traded as low as $104.70 and last traded at $104.85. Approximately 26,543 shares were traded during trading, a decline of 95% from the average daily volume of 482,678 shares. The stock had previously closed at $111.58.
新星外科(納斯達克代碼：STAA-GET)週一午盤下跌6%。該公司股價低至104.70美元，最新報104.85美元。當日成交量約為26,543股，較482,678股的日均成交量下降95%。該股此前收盤價為111.58美元。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
STAA has been the topic of a number of recent analyst reports. Benchmark increased their price target on shares of STAAR Surgical from $97.00 to $117.00 and gave the stock a "buy" rating in a report on Thursday, August 11th. Needham & Company LLC increased their price target on shares of STAAR Surgical from $87.00 to $110.00 and gave the stock a "buy" rating in a report on Thursday, August 11th. Canaccord Genuity Group increased their price target on shares of STAAR Surgical from $89.00 to $97.00 in a report on Thursday, August 11th. BTIG Research upped their price objective on shares of STAAR Surgical from $98.00 to $103.00 in a research report on Thursday, August 11th. Finally, Jefferies Financial Group reduced their price objective on shares of STAAR Surgical from $165.00 to $125.00 in a research report on Thursday, August 11th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $106.83.
STAA一直是最近多份分析師報告的主題。Benchmark在8月11日週四的一份報告中將STAAR Surgical的股票目標價從97美元上調至117.00美元，並給予該股“買入”評級。Needham&Company LLC將STAAR Surgical的股票目標價從87美元上調至110.00美元，並在8月11日星期四的一份報告中給予該股“買入”評級。在8月11日星期四的一份報告中，Canaccel Genuity Group將STAAR Surgical的股票目標價從89.00美元上調至97.00美元。BTIG Research在8月11日星期四的一份研究報告中將STAAR Surgical的股票目標價從98.00美元上調至103.00美元。最後，傑富瑞金融集團在8月11日星期四的一份研究報告中將STAAR Surgical的股票目標價從165.00美元下調至125.00美元。一名投資分析師對該股的評級為持有，五名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據，該公司目前的平均評級為“中等買入”，平均目標價為106.83美元。
STAAR Surgical Stock Down 2.7 %
STAAR外科類股下跌2.7%
The stock has a market capitalization of $4.90 billion, a price-to-earnings ratio of 152.28 and a beta of 1.09. The company's 50-day moving average is $77.11 and its 200-day moving average is $71.24.
該股市值為49.億美元，市盈率為152.28，貝塔係數為1.09.該公司50日移動均線切入位在77.11美元，200日移動均線切入位在71.24美元。
Insider Activity
內幕活動
In other news, CEO Caren L. Mason sold 35,000 shares of the firm's stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $57.49, for a total value of $2,012,150.00. Following the completion of the transaction, the chief executive officer now owns 83,645 shares of the company's stock, valued at $4,808,751.05. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.60% of the company's stock.
在其他新聞方面，首席執行官卡倫·L·梅森在5月19日星期四的一次交易中出售了3.5萬股該公司的股票。這些股票的平均價格為57.49美元，總價值為2,012,150.00美元。交易完成後，首席執行官現在擁有83,645股公司股票，價值4,808,751.05美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，該文件可在美國證券交易委員會網站上查閲。內部人士持有該公司2.60%的股份。
Institutional Inflows and Outflows
機構資金流入和流出
Several hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. boosted its stake in shares of STAAR Surgical by 0.6% in the first quarter. BlackRock Inc. now owns 5,654,613 shares of the medical instruments supplier's stock valued at $451,861,000 after purchasing an additional 31,657 shares during the period. Baillie Gifford & Co. lifted its stake in STAAR Surgical by 0.7% in the second quarter. Baillie Gifford & Co. now owns 5,285,358 shares of the medical instruments supplier's stock worth $374,890,000 after acquiring an additional 38,684 shares during the last quarter. Vanguard Group Inc. lifted its stake in STAAR Surgical by 2.5% in the first quarter. Vanguard Group Inc. now owns 5,093,250 shares of the medical instruments supplier's stock worth $407,001,000 after acquiring an additional 122,926 shares during the last quarter. State Street Corp lifted its stake in STAAR Surgical by 3.2% in the first quarter. State Street Corp now owns 1,570,063 shares of the medical instruments supplier's stock worth $125,464,000 after acquiring an additional 48,083 shares during the last quarter. Finally, Geneva Capital Management LLC lifted its stake in STAAR Surgical by 21.1% in the first quarter. Geneva Capital Management LLC now owns 909,877 shares of the medical instruments supplier's stock worth $72,708,000 after acquiring an additional 158,452 shares during the last quarter. Hedge funds and other institutional investors own 89.93% of the company's stock.
幾家對衝基金和其他機構投資者最近對他們在該業務中的頭寸進行了調整。貝萊德股份有限公司在第一季度增持了星空外科0.6%的股份。貝萊德股份有限公司在此期間增持了31,657股，目前持有這家醫療器械供應商5,654,613股股票，價值451,861,000美元。Baillie Gifford&Co.在第二季度增持了STAAR Surgical 0.7%的股份。Baillie Gifford&Co.在上個季度增持了38,684股後，現在持有這家醫療器械供應商價值374,890,000美元的5,285,358股股票。先鋒集團(Vanguard Group Inc.)第一季度增持了STAAR Surgical 2.5%的股份。先鋒集團目前持有這家醫療器械供應商的5,093,250股股票，價值407,001,000美元，此前該公司在上個季度增持了122,926股。道富集團在第一季度增持了STAAR Surgical 3.2%的股份。道富集團目前持有這家醫療器械供應商1,570,063股股票，價值125,464,000美元，此前該公司在上個季度額外收購了48,083股。最後，日內瓦資本管理有限責任公司在第一季度增持了STAAR Surgical 21.1%的股份。日內瓦資本管理有限責任公司在上個季度增持了158,452股後，現在擁有這家醫療器械供應商價值72，70.8萬美元的股票909,877股。對衝基金和其他機構投資者持有該公司89.93%的股票。
STAAR Surgical Company Profile
STAAR外科公司簡介
(Get Rating)
(獲取評級)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.
STAAR Surgical Company與其子公司一起設計、開發、製造、營銷和銷售眼科植入性鏡片，以及將鏡片輸送到眼睛內的配套輸送系統。該公司提供治療近視、遠視、散光和老花眼等視覺障礙的Visian植入式Collamer透鏡產品系列(ICL)，以及治療遠視的遠視ICL。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on STAAR Surgical (STAA)
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
- Why Apple is Primed to Take a Bite Out of Live Sports
- Exxon, Occidental Petroleum Lead Heavy Month Of Insider Buying
- Home Depot Results Point To Sluggish 2nd Half
- 免費獲取StockNews.com關於STAAR Surgical(STAA)的研究報告
- 這3只電子遊戲股票現在還在玩嗎？
- 2輛長期電動汽車的交易價格低於20美元
- 蘋果為何準備退出體育直播
- 埃克森美孚和西方石油導致內幕人士本月大量買入
- 家得寶業績指向低迷的下半年
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《STAAR外科日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對STAAR外科及相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。